Treatment of Primary Sclerosing Cholangitis with Moderate Pruritus (Skin Itching)

In patients with primary sclerosing cholangitis (PSC), pruritus — persistent skin itching — is a significant symptom that worsens quality of life and warrants structured pharmacological management when it reaches a moderate level of severity.

Clinical Scenario

This protocol is indicated for patients with established primary sclerosing cholangitis presenting with moderate pruritus. The primary clinical goal is the reduction and sustained control of pruritus.

Approach

The recommended first-line intervention belongs to the bile acid sequestrant class. The full protocol specifies the agent, the dosing range required to maintain symptom control, and the criteria for monitoring response.

The complete regimen — including agent selection, dose titration, and targets — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1038/ajg.2015.112

Bile acid sequestrants such as cholestyramine should be taken (prescribed) in patients with PSC and moderate pruritus, to reduce symptoms.

View source ↗